Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$6,272,297
+$351,961 QoQ
Shares Held
24,697
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#1,451
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $27,389,756 across 12 Drug Manufacturers - General names. JNJ ranks #1 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
24,697 | $6,272,297 | |
| 2 | ABBV |
AbbVie Inc.
|
19,932 | $5,015,688 | |
| 3 | LLY |
ELI LILLY & Co
|
3,596 | $4,313,150 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,396 | $2,955,850 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,654 | $2,911,039 | |
| 6 | AMGN |
Amgen Inc
|
7,208 | $2,610,160 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,426 | $1,004,086 | |
| 8 | AZN |
Astrazeneca PLC
|
5,241 | $993,798 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,272,297 | 24,697 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $5,920,336 | 24,220 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,095,729 | 24,623 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,491,057 | 24,221 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,624,299 | 23,727 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,419,620 | 20,620 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $3,111,788 | 21,517 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,097,128 | 19,111 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,544,060 | 17,406 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,292,489 | 14,492 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,325,708 | 14,838 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $3,318,253 | 21,305 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,272,071 | 25,810 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,692,005 | 30,271 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,682,300 | 32,167 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $5,285,186 | 32,353 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $5,684,047 | 32,021 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $5,730,023 | 32,331 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $5,515,125 | 32,239 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,588,707 | 34,605 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,532,133 | 33,581 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $5,510,491 | 33,529 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $5,825,578 | 37,016 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $5,206,631 | 34,972 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,646,977 | 33,044 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,142,658 | 31,592 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||